<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2024.1382424</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Decidual &#x3b3;&#x3b4;T cells of early human pregnancy produce angiogenic and immunomodulatory proteins while also possessing cytotoxic potential</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>N&#xf6;renberg</surname>
<given-names>Jasper</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1024372"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vida</surname>
<given-names>P&#xe9;ter</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>B&#xf6;smeier</surname>
<given-names>Isabell</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Forr&#xf3;</surname>
<given-names>Barbara</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>N&#xf6;renberg</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/103888"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buda</surname>
<given-names>&#xc1;gnes</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simon</surname>
<given-names>Diana</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/630482"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Erd&#x151;-Bony&#xe1;r</surname>
<given-names>Szabina</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1364324"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>J&#xe1;ks&#xf3;</surname>
<given-names>P&#xe1;l</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/758913"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kov&#xe1;cs</surname>
<given-names>K&#xe1;lm&#xe1;n</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mik&#xf3;</surname>
<given-names>&#xc9;va</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/675644"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berki</surname>
<given-names>T&#xed;mea</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/442408"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mez&#x151;si</surname>
<given-names>Emese</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/717517"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Barakonyi</surname>
<given-names>Al&#xed;z</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/718102"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Medical Microbiology and Immunology, University of P&#xe9;cs Medical School, Clinical Center</institution>, <addr-line>P&#xe9;cs</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>National Laboratory on Human Reproduction, University of P&#xe9;cs</institution>, <addr-line>P&#xe9;cs</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Obstetrics and Gynaecology, University of P&#xe9;cs Medical School, Clinical Center</institution>, <addr-line>P&#xe9;cs</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Pathology, University of P&#xe9;cs Medical School, Clinical Center</institution>, <addr-line>P&#xe9;cs</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Janos Szentagothai Research Centre, University of P&#xe9;cs</institution>, <addr-line>P&#xe9;cs</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Immunology and Biotechnology, University of P&#xe9;cs Medical School, Clinical Center</institution>, <addr-line>P&#xe9;cs</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>First Department of Internal Medicine, University of P&#xe9;cs Medical School, Clinical Center</institution>, <addr-line>P&#xe9;cs</addr-line>, <country>Hungary</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Maria Laura Zenclussen, National Scientific and Technical Research Council (CONICET), Argentina</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Rachel Elaine Hewitt, University of Cambridge, United Kingdom</p>
<p>Svetlana Dambaeva, Rosalind Franklin University of Medicine and Science, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Jasper N&#xf6;renberg, <email xlink:href="mailto:jasper.norenberg@pte.hu">jasper.norenberg@pte.hu</email>; Al&#xed;z Barakonyi, <email xlink:href="mailto:barakonyi.aliz@pte.hu">barakonyi.aliz@pte.hu</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1382424</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 N&#xf6;renberg, Vida, B&#xf6;smeier, Forr&#xf3;, N&#xf6;renberg, Buda, Simon, Erd&#x151;-Bony&#xe1;r, J&#xe1;ks&#xf3;, Kov&#xe1;cs, Mik&#xf3;, Berki, Mez&#x151;si and Barakonyi</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>N&#xf6;renberg, Vida, B&#xf6;smeier, Forr&#xf3;, N&#xf6;renberg, Buda, Simon, Erd&#x151;-Bony&#xe1;r, J&#xe1;ks&#xf3;, Kov&#xe1;cs, Mik&#xf3;, Berki, Mez&#x151;si and Barakonyi</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>During pregnancy, the maternal immune system must allow and support the growth of the developing placenta while maintaining the integrity of the mother&#x2019;s body. The trophoblast&#x2019;s unique HLA signature is a key factor in this physiological process. This study focuses on decidual &#x3b3;&#x3b4;T cell populations and examines their expression of receptors that bind to non-classical HLA molecules, HLA-E and HLA-G. We demonstrate that decidual &#x3b3;&#x3b4;T cell subsets, including V&#x3b4;1, V&#x3b4;2, and double-negative (DN) V&#x3b4;1-/V&#x3b4;2- cells express HLA-specific regulatory receptors, such as NKG2C, NKG2A, ILT2, and KIR2DL4, each with varying dominance. Furthermore, decidual &#x3b3;&#x3b4;T cells produce cytokines (G-CSF, FGF2) and cytotoxic mediators (Granulysin, IFN-&#x3b3;), suggesting functions in placental growth and pathogen defense. However, these processes seem to be controlled by factors other than trophoblast-derived non-classical HLA molecules. These findings indicate that decidual &#x3b3;&#x3b4;T cells have the potential to actively contribute to the maintenance of healthy human pregnancy.</p>
</abstract>
<kwd-group>
<kwd>decidua</kwd>
<kwd>&#x3b3;&#x3b4;T cells</kwd>
<kwd>HLA-E</kwd>
<kwd>HLA-G</kwd>
<kwd>NK receptors</kwd>
<kwd>cytokines</kwd>
<kwd>angiogenic factors</kwd>
<kwd>cytotoxic mediators</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="1"/>
<ref-count count="71"/>
<page-count count="12"/>
<word-count count="6601"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Immunological Tolerance and Regulation</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>During pregnancy, the coexistence of two genetically and immunologically different individuals within one body challenges primary transplantation and tumor physiology concepts. In their context, the maternal immune system&#x2019;s task is to ensure the integrity of the mother&#x2019;s body and remove foreign or dysplastic tissues. However, the maternal immune system does not attack embryonal or fetal tissues but supports implantation, placentation, and fetal growth (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>In human pregnancy, the trophoblast infiltrates deeply into the decidua and spiral arteries, allowing the establishment of a hemochorial placenta. This type of placentation, in which maternal blood is in direct contact with fetal tissues, ensures a sufficient supply of oxygen and nutrients. Insufficient supply, caused by weak trophoblast invasion during the first trimester, may lead to human pregnancy disorders, like fetal growth restriction or preeclampsia (<xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B6">6</xref>). Furthermore, early pregnancy loss or infertility cases might be connected to even weaker implantation and invasion. Research of the last decades emphasizes the importance of the interaction of trophoblast and decidua for controlling invasion depth and establishing a healthy placenta (<xref ref-type="bibr" rid="B7">7</xref>&#x2013;<xref ref-type="bibr" rid="B9">9</xref>). Cases of the placenta accreta spectrum, in which the trophoblast might even invade neighboring organs, highlight the role of the decidua in this process as they commonly occur when the blastocyte implants at the site of a uterine scar, where decidua is absent (<xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>).</p>
<p>At the time of receptivity (window of implantation), leukocytes accumulate in the decidua, dominated by a unique CD56<sup>bright</sup> innate lymphoid cell population, commonly known as uterine/decidual NK (u/dNK) cells (<xref ref-type="bibr" rid="B12">12</xref>). Decidual NK cells have an array of activating and inhibiting receptors, which bind specific classical and non-classical HLA class I molecules (<xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>). The extravillous cytotrophoblast (EVT), which is in direct contact with the decidua and invades uterine spiral arteries (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>), is unique in its HLA class I expression pattern: The highly variable HLA-A and -B are not expressed by the EVT. Instead, its cells express HLA-C and the oligomorphic HLA-E and -G on their cell surface. Under physiological circumstances, HLA-G is exclusively known to be expressed by the EVT (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Next to the membrane-bound form of HLA-E and HLA-G (mHLA-E/-G), soluble forms (sHLA-E/-G) have been found in the sera of pregnant women (<xref ref-type="bibr" rid="B20">20</xref>&#x2013;<xref ref-type="bibr" rid="B23">23</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>
<bold>(A)</bold> Illustration of anatomical structure and spatial relations at the feto-maternal interface. <bold>(B)</bold> Representative isolated depiction of tSNE-clustered decidual (left) and maternal peripheral blood (right) &#x3b3;&#x3b4;T cells as density plots (n=1; Panel A, also see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;1B</bold>
</xref>). <bold>(C)</bold> Representative tSNE-plot depicting fluorescence intensity of CD56-PE/Dazzle594&#x2122; on &#x3b3;&#x3b4;T cells from peripheral blood and decidua (n=1; Panel A, also see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;1C</bold>
</xref>). <bold>(D)</bold> Statistical comparison of CD56<sup>+</sup> cells&#x2019; prevalence among &#x3b3;&#x3b4;T cells from the decidua (n=22) and peripheral blood (n=23) (see also <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;1D</bold>
</xref>). <bold>(E)</bold> Representative contour plot overlay of V&#x3b4;1<sup>+</sup>, V&#x3b4;2<sup>+</sup>, and DN &#x3b3;&#x3b4;T cells on clustered &#x3b3;&#x3b4;T cells from peripheral blood and decidua (n=1; Panel A, also see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;1E</bold>
</xref>). <bold>(F)</bold> Statistical comparison of V&#x3b4;1<sup>+</sup>, V&#x3b4;2<sup>+</sup>, and DN &#x3b3;&#x3b4;T cells&#x2019; prevalence among &#x3b3;&#x3b4;T cells from the decidua (n=22) and peripheral blood (n=23). Testing for significance was performed with the Wilcoxon test. *: p &#x2264; 0.05, ***: p &#x2264; 0.001, ****: p &#x2264; 0.0001; ST, syncytiotrophoblast; VCT, villous cytotrophoblast; F, fibroblast; HB, Hofbauer cell; (d)NK, (decidual) Natural killer cell; T, T cell; s/mHLA, soluble/membrane-bound Human Leukocyte Antigen class I; EVT, extravillous cytotrophoblast; S, stroma cell; M&#x3c6;, Macrophage.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1382424-g001.tif"/>
</fig>
<p>Next to dNK cells, &#x3b3;&#x3b4;T cells and their potential roles during pregnancy have attracted interest. They are well known to surveil the tissue integrity of frontiers between the organism and the environment (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). Studies reported a higher prevalence of &#x3b3;&#x3b4;T cells among decidual CD3<sup>+</sup> cells compared to the peripheral blood (<xref ref-type="bibr" rid="B26">26</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>). These decidual &#x3b3;&#x3b4;T cells, like dNK cells, are either clustered proximate to decidual glands or scattered as intraepithelial lymphocytes (<xref ref-type="bibr" rid="B26">26</xref>). The association of decidual &#x3b3;&#x3b4;T cells and dNK cells to glands might be connected to the invasion of the EVT, as the EVT penetrates not only spiral arteries but uterine glands (<xref ref-type="bibr" rid="B29">29</xref>). A growing body of evidence attributes a central role to these glands, providing nutrients, growth factors, and cytokines during placentation (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B31">31</xref>).</p>
<p>Innate lymphoid cells, like dNK cells, and &#x3b3;&#x3b4;T are closely related. Although &#x3b3;&#x3b4;T cells have an antigen-recognition receptor, they rely on an arsenal of cytotoxicity receptors for their activity. Furthermore, in contrast to &#x3b1;&#x3b2;T cells, they are not MHC-restricted for their antigen recognition. However, some of these cytotoxicity-related receptors bind HLA class I molecules and transmit activating or inhibiting signaling upon ligation. Consequently, HLA expression is likely to influence &#x3b3;&#x3b4;T cell behavior.</p>
<p>Considering the EVT&#x2019;s unique HLA class I expression profile, three receptor groups come into focus at the maternal-fetal interface. The NKG2 receptor family, with a particular emphasis on activating NKG2C and inhibitory NKG2A, plays a pivotal role in recognizing HLA-E expression (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). HLA-G, conversely, can be bound by KIR2DL4, a receptor from the Killer cell Immunoglobulin-like Receptor (KIR) family (CD158). This family is mainly known for HLA-C binding. However, KIR2DL4 stands out among the KIR receptor family due to its unique ligand preference, location, and function. Unlike other KIR receptors, KIR2DL4 is predominantly located intracellularly and is only expressed on the cell surface during activation states. Although its molecular structure suggests an inhibitory function, KIR2DL4-ligation was shown to trigger cytokine release (<xref ref-type="bibr" rid="B34">34</xref>&#x2013;<xref ref-type="bibr" rid="B36">36</xref>). Last, Immunoglobulin-like transcript (ILT2), a member of the leukocyte immunoglobulin-like receptor subfamily B, binds HLA class I molecules, including HLA-G, and transmits an inhibitory signal upon ligation (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B33">33</xref>).</p>
<p>In addition, the non-classical MHC molecule CD1d, which presents lipid antigens, has the potential to facilitate antigen recognition through the &#x3b3;&#x3b4;TCR (<xref ref-type="bibr" rid="B37">37</xref>&#x2013;<xref ref-type="bibr" rid="B39">39</xref>). However, further signals will influence the crosstalk between maternal &#x3b3;&#x3b4;T cells and the fetal EVT in the decidua. Although, investigations in tumor immunology have already demonstrated the expression of different non-classical HLA receptors (<xref ref-type="bibr" rid="B40">40</xref>), a detailed expression profile of these receptors on decidual &#x3b3;&#x3b4;T cells has not been published.</p>
<p>Here, we present an expression profile for HLA-E- or HLA-G-binding receptors of decidual &#x3b3;&#x3b4;T cells during early pregnancy. Furthermore, we investigated the potential consequences of respective receptor-ligand interactions. In this context, we focused on &#x3b3;&#x3b4;T cells&#x2019; secretion of mediators, which may influence vascular transformation or pathogen defense.</p>
</sec>
<sec id="s2" sec-type="results">
<label>2</label>
<title>Results</title>
<sec id="s2_1">
<label>2.1</label>
<title>Heterogeneity of peripheral and decidual &#x3b3;&#x3b4;T cells during early pregnancy</title>    <p>We found no significant difference between decidual and peripheral blood &#x3b3;&#x3b4;T cells&#x2019; prevalence among CD45<sup>+</sup>/live cells (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;1A</bold>
</xref>). To characterize decidual &#x3b3;&#x3b4;T cells and compare them to their circulating counterparts, we utilized the downsampling plugin of FlowJo&#x2122; and concatenated previously gated &#x3b3;&#x3b4;T cell populations from decidual mononuclear cells (DMCs) and peripheral blood mononuclear cells (PBMCs). Defined separate clusters with minimal overlap were assigned to decidual or peripheral blood &#x3b3;&#x3b4;T cells, respectively (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A, B</bold>
</xref>, see also <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;1B</bold>
</xref>).</p>    <p>Due to the biological similarities between NK cells and &#x3b3;&#x3b4;T, we investigated the expression of CD56 on &#x3b3;&#x3b4;T cells. While CD56<sup>dim</sup> expression was detectable in several peripheral blood &#x3b3;&#x3b4;T cell clusters, decidual &#x3b3;&#x3b4;T cells exhibited both CD56<sup>dim</sup> and CD56<sup>bright</sup> phenotypes (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>, see also <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;1C</bold>
</xref>). Nevertheless, CD56<sup>+</sup> &#x3b3;&#x3b4;T cells are more prevalent in the decidua than in the periphery (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>, see also <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;1D</bold>
</xref>).</p>    <p>Classical &#x3b3;&#x3b4;T cell subsets were associated with distinct clusters. V&#x3b4;1<sup>+</sup> (CD45<sup>+</sup>TCR&#x3b3;&#x3b4;<sup>+</sup>V&#x3b4;1<sup>+</sup>V&#x3b4;2<sup>&#x2013;</sup>) cells were more prevalent in the decidua, while V&#x3b4;2<sup>+</sup> (CD45<sup>+</sup>TCR&#x3b3;&#x3b4;<sup>+</sup>V&#x3b4;1<sup>&#x2013;</sup>V&#x3b4;2<sup>+</sup>) cells were more common among circulating &#x3b3;&#x3b4;T cells. However, double-negative (DN, CD45<sup>+</sup>TCR&#x3b3;&#x3b4;<sup>+</sup>V&#x3b4;1<sup>&#x2013;</sup>V&#x3b4;2<sup>&#x2013;</sup>) &#x3b3;&#x3b4;T cells were the most common in both decidual and peripheral blood (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1E, F</bold>
</xref>, see also <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;1F</bold>
</xref>).</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Decidual &#x3b3;&#x3b4;T subsets express receptors that bind to HLA-E or HLA-G molecules</title>
<p>Using two flow cytometric panels (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;6</bold>
</xref>), we investigated the prevalence and expression of HLA-E and HLA-G-binding receptors (NKG2C, NKG2A, and ILT2, KIR2DL4, respectively) on &#x3b3;&#x3b4;T cell subsets in the decidua and the matched peripheral blood (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>, see also <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;1B, E</bold>
</xref>). To estimate the expression intensity, we compared the median fluorescence intensity (normalized to the respective FMO) of all investigated receptors. Peripheral &#x3b3;&#x3b4;T cells show higher expression intensity for KIR2DL4 or ILT2 receptors than that for NKG2C and NKG2A. Within the different decidual &#x3b3;&#x3b4;T cell subpopulations, decidual DN &#x3b3;&#x3b4;T cells exhibited relatively high expression levels for all investigated receptors, while decidual V&#x3b4;1<sup>+</sup> cells showed a more focused expression of the activating NKG2C and the inhibiting ILT2. In contrast, decidual V&#x3b4;2<sup>+</sup> cells expressed significantly more NKG2A on their cell surface (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>, see also <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;2A, B</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>
<bold>(A)</bold> Expression distribution of NKG2C-PE (upper left), NKG2A-APC (upper right) of flow cytometric Panel A, ILT2-PE (lower left, see also <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;A/D</bold>
</xref>), and KIR2DL4-APC (lower right, see also <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;A/D</bold>
</xref>) of flow cytometric panel B depicted as representative tSNE plots of paired, concatenated decidual and peripheral blood &#x3b3;&#x3b4;T cells (n=1). <bold>(B)</bold> Heatmap of standardized median fluorescence intensity ([Median<sub>Subset</sub>-Median<sub>FMO</sub>]/rSD<sub>FMO</sub>) of NKG2C-PE, NKG2A-APC, ILT2-PE, KIR2DL4-APC on matched decidual and peripheral blood &#x3b3;&#x3b4;T cell subsets (n=22; also see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;2</bold>
</xref>). <bold>(C)</bold> Statistical comparison of NKG2C<sup>+</sup> cells&#x2019; prevalence among &#x3b3;&#x3b4;T cells from the decidua (n=22) and peripheral blood (n=23). <bold>(D)</bold> Statistical comparison of NKG2A<sup>+</sup> cells&#x2019; prevalence among &#x3b3;&#x3b4;T cells from the decidua (n=22) and peripheral blood (n=23). <bold>(E)</bold> Statistical comparison of ILT2<sup>+</sup> cells&#x2019; prevalence among &#x3b3;&#x3b4;T cells from the decidua (n=22) and peripheral blood (n=23). <bold>(F)</bold> Statistical comparison of KIR2DL4<sup>+</sup> cells&#x2019; prevalence among &#x3b3;&#x3b4;T cells from the decidua (n=22) and peripheral blood (n=23). Testing for significance was performed with the Kruskal-Wallis test. *: p &#x2264; 0.05, **: p &#x2264; 0.01, ***: p &#x2264; 0.001****: p &#x2264; 0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1382424-g002.tif"/>
</fig>
<p>The prevalence of NKG2C<sup>+</sup> cells was generally higher among decidual &#x3b3;&#x3b4;T cells compared to the periphery. However, this difference reached the level of significance only in the V&#x3b4;2<sup>+</sup> and DN subsets. Furthermore, NKG2C positivity was significantly more common in the V&#x3b4;1<sup>+</sup> subset compared to the V&#x3b4;2<sup>+</sup> one (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). Likewise, cells expressing the inhibitory counterpart NKG2A were more prevalent in the decidua. While the percentage of NKG2A<sup>+</sup> cells among V&#x3b4;2<sup>+</sup> cells did not differ between decidua and peripheral blood, a significantly higher proportion of DN &#x3b3;&#x3b4;T cells expresses NKG2A and NKG2C in the decidua compared to the periphery (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>).</p>
<p>The inhibitory HLA-G-binding ILT2 was commonly expressed by &#x3b3;&#x3b4;T cells independently of their origin. Generally, ILT2<sup>+</sup> cells were less prevalent in the V&#x3b4;2<sup>+</sup> subsets than in other &#x3b3;&#x3b4;T cell populations. However, when focusing on the prevalence of ILT2<sup>+</sup> cells within each &#x3b3;&#x3b4;T cell subset, significantly fewer decidual DN &#x3b3;&#x3b4;T cells expressed ILT2 than their peripheral blood counterpart (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>). The HLA-G-binding KIR2DL4 was expressed by the majority of &#x3b3;&#x3b4;T cells (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2F</bold>
</xref>).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Decidual &#x3b3;&#x3b4;T cells secrete trophoblastotropic cytokines</title>
<p>To determine the functional consequences of the HLA-E or -G recognition by &#x3b3;&#x3b4;T cells, we incubated purified &#x3b3;&#x3b4;T cells with soluble HLA-E or -G (sHLA-E/-G). Furthermore, we utilized human choriocarcinoma cell lines (JAr) transfected with HLA-E or HLA-G<sub>1m</sub> to investigate more complex interactions of membrane-bound HLA-E or -G (mHLA-E/-G) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>
<bold>(A)</bold> Illustration of the experimental setup. <bold>(B)</bold> Heatmap depicting the z-score of the respective angiogenic factor after incubating peripheral blood (left) or decidual (right) &#x3b3;&#x3b4;T cells with soluble (s) or membrane-bound (m)HLA-E or -G. The last column depicts measurements from the human choriocarcinoma cell line JAr without &#x3b3;&#x3b4;T cells as an additional control (also see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;3</bold>
</xref>). <bold>(C)</bold> Statistical comparison of G-CSF concentrations secreted from decidual (n=7) or peripheral blood (n=7) &#x3b3;&#x3b4;T cells without HLA molecules. Testing for significance was performed with the Wilcoxon matched-pairs signed rank test. <bold>(D)</bold> Statistical comparison of FGF-2 concentrations secreted from decidual (n=7) or peripheral blood (n=7) &#x3b3;&#x3b4;T cells without HLA molecules. Testing for significance was performed with the Wilcoxon matched-pairs signed rank test. <bold>(E)</bold> Statistical comparison of EGF concentrations secreted from decidual (n=7) or peripheral blood (n=7) &#x3b3;&#x3b4;T cells without HLA molecules. Testing for significance was performed with the Wilcoxon matched-pairs signed rank test. <bold>(F)</bold> Statistical comparison of Leptin concentrations measured after incubating peripheral blood or decidual &#x3b3;&#x3b4;T cells with sHLA or mHLA molecules. Testing for significance was performed with the Kruskal-Wallis test. <bold>(G)</bold> Statistical comparison of Follistatin concentrations measured after incubating peripheral blood or decidual &#x3b3;&#x3b4;T cells with sHLA or mHLA molecules. Testing for significance was performed with the Kruskal-Wallis test. *: p &#x2264; 0.05, **: p &#x2264; 0.01, ***: p &#x2264; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1382424-g003.tif"/>
</fig>
<p>Vascular transformation by the trophoblast and the local immune environment is crucial to establishing a healthy placenta during early pregnancy. Therefore, we analyzed the collected cell co-culture supernatants for potential angiogenic cytokines (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). When comparing peripheral blood to decidual &#x3b3;&#x3b4;T cells without HLA molecules (&#x201c;Control (sHLA)&#x201d; in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>), we found significantly higher levels of G-CSF produced by the decidual ones (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). Furthermore, decidual &#x3b3;&#x3b4;T cells produced FGF-2, whereas no FGF-2 was detected in the wells of peripheral &#x3b3;&#x3b4;T cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). On the other hand, peripheral blood &#x3b3;&#x3b4;T cells produce small amounts of EGF, which was not detected in the wells of decidual samples (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). While the production of most measured cytokines was not influenced by the presence or absence of HLA-E or -G molecules in our experimental model, incubating mHLA-G with &#x3b3;&#x3b4;T cells, independently from their origin, increased the measured Leptin concentrations (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>). Additionally, we detected elevated concentrations of Follistatin when incubating peripheral blood &#x3b3;&#x3b4;T cells with mHLA-E. However, compared to all other co-culture wells, the level of significance was not reached (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3G</bold>
</xref>).</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Decidual &#x3b3;&#x3b4;T cells are strong producers of cytotoxic mediators</title>    <p>&#x3b3;&#x3b4;T cells act as first responders in the mucosal defense against pathogens and many frontiers between the body and its environment. Therefore, we also analyzed the intracellular perforin content to determine each &#x3b3;&#x3b4;T cell subset&#x2019;s cytotoxic potential in the decidua. Although in the periphery significantly less intracellular Perforin was measured in DN &#x3b3;&#x3b4;T cells compared to the V&#x3b4;2 population (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;4A, B</bold>
</xref>), the Perforin content of the different &#x3b3;&#x3b4;T cell subsets did not differ in the decidua. <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref> confirms the distinct features of Perforin-positive decidual &#x3b3;&#x3b4;T cell subpopulations, as analyzed in our two flow cytometric antibody panels. (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>, see also <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;4A, B</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>
<bold>(A)</bold> Fluorescence intensity of Perforin-VioBlue<sup>&#xae;</sup> on gated &#x3b3;&#x3b4;T cell subsets from the decidua for the two flow cytometric panels depicted as representative tSNE plots (n=1). <bold>(B)</bold> Statistical association of standardized Perforin-VioBlue<sup>&#xae;</sup> median fluorescence intensity ([Median<sub>Subset</sub>-Median<sub>FMO</sub>]/rSD<sub>FMO</sub>) to the expression of NKG2C, NKG2A, ILT2, and KIR2DL4 on decidual &#x3b3;&#x3b4;T cell subsets (n=22). Testing for significance was performed with the Wilcoxon matched-pairs signed rank test. <bold>(C)</bold> Heatmap depicting the z-score of the respective soluble factor after incubating decidual (left) or peripheral blood (right) &#x3b3;&#x3b4;T cells with soluble (s) or membrane-bound (m) HLA-E or -G. <bold>(D)</bold> Statistical comparison of Perforin concentrations measured after incubating peripheral blood or decidual &#x3b3;&#x3b4;T cells with sHLA or mHLA molecules. Testing for significance was performed with the Kruskal-Wallis test. <bold>(E)</bold> Statistical comparison of Granulysin (left) and INF-&#x3b3; (right) concentrations secreted from decidual (n=6) or peripheral blood (n=6) &#x3b3;&#x3b4;T cells in the absence of HLA molecules. Testing for significance was performed with the Wilcoxon matched-pairs signed rank test. *: p &#x2264; 0.05, **: p &#x2264; 0.01, ***: p &#x2264; 0.001, ****: p &#x2264; 0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1382424-g004.tif"/>
</fig>
<p>Upon interaction with HLA-E or HLA-G, NKG2C, NKG2A, ILT2, and KIR2DL4 are potential regulators of the cytotoxic capability of immune cells. Investigating the perforin content of the different NK receptor-expressing decidual &#x3b3;&#x3b4;T cell populations, we found that the expression of NKG2C and ILT2 was associated with significantly higher levels of intracellular perforin in all decidual &#x3b3;&#x3b4;T cell subsets. The expression of NKG2A, however, correlated only in the V&#x3b4;1<sup>+</sup> and DN &#x3b3;&#x3b4;T subset with higher levels of intracellular perforin. A similar, significant relation between KIR2DL4 expression and perforin content was only detectable in the DN &#x3b3;&#x3b4;T cell subset (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>).</p>    <p>To determine if this hypothetical relationship between cytotoxicity and the expression of HLA class I binding receptors has functional consequences, we analyzed the secretion of typical NK cell cytokines and cytotoxicity-related soluble molecules after exposure to sHLA-E/-G or mHLA-E/-G (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>, see also <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;4C-N</bold>
</xref>). However, the measured perforin concentration did not differ significantly (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>). In addition, we found that decidual &#x3b3;&#x3b4;T cells secrete excessive amounts of granulysin and high levels of interferon-&#x3b3; (IFN-&#x3b3;) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>).</p>
</sec>
</sec>
<sec id="s3" sec-type="discussion">
<label>3</label>
<title>Discussion</title>
<p>Decidual &#x3b3;&#x3b4;T cells may have several functions in the microenvironment of the maternal-fetal interface between the decidua basalis and the extravillous trophoblast. They could influence the process of implantation and placentation via cytokine secretion or clear out pathogens.</p>
<p>The prevalence of &#x3b3;&#x3b4;T cells among CD45<sup>+</sup>/live cells was not different between the decidua and the peripheral blood. However, it is important to note that literature data shows that while the prevalence of T cells (CD3<sup>+</sup>) among all lymphocytes is around 70% in the peripheral blood, it is only around 15% in the early human decidua (<xref ref-type="bibr" rid="B41">41</xref>). Furthermore, according to previously published data, the population of &#x3b3;&#x3b4;T cells is markedly expanded in the decidua compared to the periphery (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Thus, due to the lack of CD3 staining, our prevalence data must be interpreted carefully.</p>
<p>As &#x3b3;&#x3b4;T cells exhibit innate and adaptive immunity aspects, they are often described as a bridge between these two parts of the immune system. Although a more didactic subdivision, &#x3b3;&#x3b4;T cells show quite some plasticity, and some subsets (e.g., V&#x3b3;9V&#x3b4;2) behave more in an innate manner, while others (e.g., V&#x3b4;1) show rather adaptive features (<xref ref-type="bibr" rid="B42">42</xref>&#x2013;<xref ref-type="bibr" rid="B49">49</xref>). Therefore, when investigating &#x3b3;&#x3b4;T cells in any context, determining the prevalent subpopulations is a crucial first step before further conclusions.</p>
<p>The increase in the V&#x3b4;1 subset is typical for all tissues that frontier the environment and is often understood as a &#x201c;first line defense&#x201d; (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B50">50</xref>). Our data on the prevalence of V&#x3b4;1 and V&#x3b4;2 subsets are in line with previously published flow cytometric data (<xref ref-type="bibr" rid="B51">51</xref>). However, these publications ignored the largest decidual &#x3b3;&#x3b4;T cell population, which expresses neither the V&#x3b4;1 nor the V&#x3b4;2 chain. Different variants of V&#x3b4;-chains exist, which makes DN &#x3b3;&#x3b4;T cells a heterogeneous population. However, a recent study used sequencing to show that the early human decidua is only inhabited by the V&#x3b4;1<sup>+</sup>, V&#x3b4;2<sup>+</sup>, and V&#x3b4;3<sup>+</sup> &#x3b3;&#x3b4;T cell subsets (<xref ref-type="bibr" rid="B52">52</xref>). Therefore, DN &#x3b3;&#x3b4;T cells of the decidua can be considered as V&#x3b4;3<sup>+</sup> cells. The V&#x3b4;3 subset is generally assumed to induce antigen-presenting cell maturation (<xref ref-type="bibr" rid="B53">53</xref>). In the context of pregnancy, the correct presentation of antigens is essential. Further investigations will be necessary to determine if decidual V&#x3b4;3 cells could direct antigen-presenting cell maturation toward a tolerance-promoting phenotype. Currently, anti-V&#x3b4;3 antibodies are not commercially available. Therefore, we cannot finally confirm that the DN subset represents the V&#x3b4;3-one, so henceforward, we refer to this population as DN &#x3b3;&#x3b4;T cells.</p>
<p>Interestingly, the majority of decidual &#x3b3;&#x3b4;T cells are CD56<sup>+</sup>, suggesting a special characteristic for decidual &#x3b3;&#x3b4;T cells. In addition, all three &#x3b3;&#x3b4;T cell populations contain cell clusters of CD56-expressing cells, which are more prevalent in the decidua. Although these decidual &#x2018;NK&#x3b3;&#x3b4;T-like&#x2019; cells may be associated with dNK cells, as the expression of CD56 on lymphoid cells serves rather as a phenotypical marker, conclusions must be made carefully. To date, investigations indicating physiological similarities are still outstanding.</p>
<p>As mentioned previously, the trophoblast&#x2019;s unique expression pattern of HLA class I molecules is crucial in allowing temporal chimerism during pregnancy. HLA molecules are absent at the maternal-fetal interface between the circulating maternal blood and the fetal syncytiotrophoblast in the intervillous spaces, which may explain why circulating adaptive immune cells do not drive an immune response at this location. However, the decidua directly interacts with the extravillous trophoblast expressing HLA-C, HLA-E, and HLA-G. Under physiological circumstances, HLA-G is uniquely expressed at this interface and is believed to influence the maternal immune system to accept and support viviparity. The expression of HLA-E, on the other hand, is connected to the expression of other HLA class I molecules, as it is loaded with their leader sequence peptides. Therefore, its expression on the cell surface usually is proportional to a given cell&#x2019;s HLA class I expression level (<xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B55">55</xref>). In cases of viral infection or malignancies, the expression of HLA class I molecules may alter, which consequently will be reflected in the expression of HLA-E. This can be detected by NK or cytotoxic T cells via the activating receptor NKG2C or the inhibitory receptor NKG2A. However, tumors may utilize upregulated HLA-E expression or secretion as an escape mechanism. Therefore, the extravillous trophoblast&#x2019;s HLA-E positivity might simply result from its HLA-G expression.</p>
<p>Control of &#x3b3;&#x3b4;T cell function is essential, where trophoblast-expressed non-classical HLA molecules could serve as potent mediators. Among all decidual &#x3b3;&#x3b4;T cell subsets, cells expressing receptors for HLA-E or HLA-G are prevalent, suggesting an efficient influence of these non-classical HLA molecules. Especially the decidual V&#x3b4;1<sup>+</sup> subset shows high expression levels of NKG2C and co-expresses NKG2A with lower intensity. However, considering the higher affinity of NKG2A to HLA-E, this difference in surface expression may be irrelevant (<xref ref-type="bibr" rid="B32">32</xref>). Both ILT2 and KIR2DL4 have been shown to bind various ligands, including HLA-G (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Next to its physiological expression and secretion by the EVT during pregnancy, malignancies are known to express and secret HLA-G. In this context, its ITL2-mediated inhibitory effects on V&#x3b3;9V&#x3b4;2 cells are well known [reviewed in (<xref ref-type="bibr" rid="B56">56</xref>)], and similar effects can be expected in the decidual microenvironment. KIR2DL4 is a unique Killer cell immunoglobulin-like receptor family member, as it is reportedly expressed on the cell surface or intracellularly by activated or non-activated NK cells. According to our findings, both decidual and peripheral &#x3b3;&#x3b4;T cells only express KIR2DL4 intracellularly. Considering its location, interactions with sHLA-G are more likely. However, intercellular HLA-G transfer through mechanisms like trogocytosis, nanotube transfer, or exosome provides an alternative possibility for KIR2DL4-HLA-G interactions (<xref ref-type="bibr" rid="B57">57</xref>). Despite its molecular structure suggesting an inhibitory function, it has been shown that the consequence of its ligation depends on the context. Rajagopalan et&#xa0;al., for example, demonstrated the production of angiogenic factors by peripheral blood NK cells due to KIR2DL4 ligation (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B58">58</xref>).</p>
<p>For deeper investigation of the role of HLA-E and HLA-G in the functional control of different &#x3b3;&#x3b4;T cell subpopulations in the decidua, we analyzed the proportions of HLA class I-binding receptor expressing decidual &#x3b3;&#x3b4;T subsets. Decidual V&#x3b4;2 cells showed a reduced potential for activation and an increased potential for inhibition via HLA-E. Therefore, we suppose that HLA-E could be responsible, among others, for the control of V&#x3b4;2 cell function in the placenta. Regarding HLA-G, our data suggest that this non-classical HLA molecule preferentially regulates not only decidual &#x3b3;&#x3b4;T cells but also peripheral V&#x3b4;1 and DN &#x3b3;&#x3b4;T cells in its soluble form. These effects are mediated through ILT2 and KIR2DL4 receptor functions. In addition, because of the high ratio of KIR2DL4 expressing peripheral V&#x3b4;2 cells, soluble HLA-G is potentially able to inhibit V&#x3b4;2 cells also. This peripheral inhibition of &#x3b3;&#x3b4;T cell subsets could be part of the known systemic immunological adaptation during pregnancy, which could be measured in the peripheral blood also.</p>
<p>A further interesting issue is whether peripheral and decidual &#x3b3;&#x3b4;T cells differ in their NK cell receptor expression patterns. Regarding the proportion of NK receptor-positive cells, decidual V&#x3b4;1 or V&#x3b4;2 cells do not differ significantly in their inhibitory NK receptor expression pattern from their peripheral counterpart; however, decidual and peripheral DN &#x3b3;&#x3b4;T cells are phenotypically different and therefore show presumably distinct regulation by the non-classical HLA molecules. Here, in contrast to the peripheral DN &#x3b3;&#x3b4;T cells, the binding of the HLA-E molecule can result in both inhibitory and activating signals in the decidua. Whereas HLA-G primarily inhibits decidual DN &#x3b3;&#x3b4;T cells via KIR2DL4 rather than ILT2.</p>
<p>Although activated decidual &#x3b3;&#x3b4;T cells produce angiogenic factors (G-CSF, FGF-2), the presence of HLA-G did not affect their production <italic>in vitro</italic>. G-CSF is also secreted by decidual NK cells and promotes the disorganization of vascular muscles. This, in turn, aids the invasion of the extravillous trophoblast into the spiral arteries, increasing the blood supply in the placental bed (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>). FGF-2, on the other hand, activates MAPK signaling and was assumed to improve endometrial receptivity (<xref ref-type="bibr" rid="B61">61</xref>). Furthermore, it was demonstrated that FGF-2 improves proliferation and survival of trophoblast organoid cultures <italic>in vitro</italic> (<xref ref-type="bibr" rid="B62">62</xref>). Although the concentrations of FGF-2 in our experiments were significantly lower than in the the trophoblast culture experiments, it demonstrates that decidual &#x3b3;&#x3b4;T cells contribute to the creation of a nursing environment for the invading trophoblast. Leptin is produced by trophoblast tissue and is known to support trophoblast invasion (<xref ref-type="bibr" rid="B63">63</xref>). Administration of leptin increases HLA-G expression on the EVT <italic>in vitro</italic> (<xref ref-type="bibr" rid="B64">64</xref>). In this context, we hypothesize that higher leptin concentrations could be connected to the expression of HLA-G itself, indicating an interdependent relationship between HLA-G expression and leptin secretion. In our experiments, leptin concentrations increased only in the presence of decidual but also peripheral blood &#x3b3;&#x3b4;T cells, without a significant difference between the two experimental settings. This generally emphasizes the relevance of immune cells for leptin secretion. Other angiogenic factors like endoglin, placenta growth factor, or vascular endothelial growth factor, which were detected in our experiments, are known to be secreted by trophoblast tissue (<xref ref-type="bibr" rid="B65">65</xref>).</p>
<p>Regarding potential defense mechanisms, decidual &#x3b3;&#x3b4;T cells&#x2019; intracellular perforin level correlates positively with NKG2C and ILT2 expression on all &#x3b3;&#x3b4;T subsets and with NKG2A for V&#x3b4;1 and DN subsets. However, our experiments do not show altered secretion of perforin in the presence of HLA-E or -G. While innate lymphoid cells utilize various activating and inhibiting receptors for their activity, &#x3b3;&#x3b4;T cells can use their TCR for antigen recognition. Our results suggest no immediate consequences for the isolated presence of either HLA-E or -G. However, long-term consequences are possible and likely. In peripheral blood NK cells, these receptors are not just associated with immediate cell reaction but also with a process of activation threshold alteration called NK cell education (<xref ref-type="bibr" rid="B66">66</xref>). We suggest a similar process might also be possible for &#x3b3;&#x3b4;T cells.</p>
<p>Decidual &#x3b3;&#x3b4;T cells secrete high levels of IFN-&#x3b3; and impressive levels of granulysin. This emphasizes their importance in pathogen defense, as granulysin allows pathogen eradication from virus-infected trophoblast cells without harming the trophoblast itself (<xref ref-type="bibr" rid="B67">67</xref>).</p>
<p>Our findings highlight the multifaceted functions and interactions of &#x3b3;&#x3b4;T cells in decidua during the first trimester, confirming the concept that &#x3b3;&#x3b4;T cells are potential effector immune cells at the feto-maternal interface, contributing to healthy pregnancy. The presented data provide further evidence that decidual &#x3b3;&#x3b4;T lymphocytes significantly differ from peripheral &#x3b3;&#x3b4;T cells - they produce angiogenic and immunomodulatory proteins, have conserved or even increased cytotoxic potential, and they could be controlled by non-classical HLA molecules. Accordingly, HLA-G and HLA-E, expressed by EVT can influence decidual &#x3b3;&#x3b4;T cell function through receptors like NKG2C, NKG2A, ILT2, and KIR2DL4, which interactions may modulate immune responses, adding another layer of complexity to the maternal-fetal interface. However, the detailed consequences of the cross-linking of the non-classical HLA molecules and their receptors on the different &#x3b3;&#x3b4;T cell subpopulations remain to be elucidated in the future. Moreover, our study also reveals the potential research interest of the under-researched DN &#x3b3;&#x3b4;T cell population, which could be a promising target for further investigations in reproductive immunology.</p>
</sec>
<sec id="s4" sec-type="materials|methods">
<label>4</label>
<title>Materials and methods</title>
<sec id="s4_1">
<label>4.1</label>
<title>Human samples</title>
<p>Decidual tissue samples and matched peripheral blood were obtained from healthy pregnant women (n = 27, age <italic>(mean &#xb1; SD)</italic> = 25.9 &#xb1; 1.4) undertaking an elective pregnancy termination during the first trimester (gestational age <italic>(mean &#xb1; SD)</italic>= 9.3 &#xb1; 0.3) in the Department of Obstetrics and Gynecology, University of P&#xe9;cs, Medical School, Hungary.</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>Isolation of decidual mononuclear cells</title>
<p>The pregnancy was terminated by vacuum aspiration, and the collected tissue was immediately processed. First, the collected decidual pieces were macroscopically homogenized with scissors (approximately 2 mm<sup>3</sup>). Hereafter, the tissue was resuspended with prewarmed (37&#xb0;C) collagenase type IV (1 mg/mL, Gibco<sup>&#xae;</sup>) and transferred to C-tubes (Miltenyi Biotec). To create a single-cell solution, the samples were then further dissected using a gentleMACS&#x2122; dissociator (Miltenyi Biotec) with three fast contrarotating cycles (800 rpm/25 sec/cycle) and slow agitation (40 rpm) for one hour at 37&#xb0;C. After that, the cells were collected through successive 100 &#xb5;m, 70 &#xb5;m, and 40 &#xb5;m nylon cell strainers (Miltenyi Biotec) and washed in RPMI1640 medium (Lonza) supplemented with penicillin (1 x 10<sup>5</sup> U/L) (Lonza) and streptomycin (0.05 g/L) (Lonza). In the next step, decidual mononuclear cells (DMCs) were isolated by Ficoll-Paque&#x2122; (GE Healthcare) gradient centrifugation. The collected cells were washed and resuspended in RPMI1640 medium (Lonza) containing 20% fetal calf serum (Gibco<sup>&#xae;</sup>) supplemented with penicillin (1 x 10<sup>5</sup> U/L) (Lonza) and streptomycin (0.05 g/L) (Lonza). The resuspended cells were distributed onto cell culture dishes and incubated overnight at 37&#xb0;C and 5% CO<sub>2</sub> to allow the remaining decidual stroma cells to settle and adhere. The next morning, the non-adherent cells were aspirated, washed, controlled for viability with trypan blue, and split for cryopreservation and isolation of &#x3b3;&#x3b4;T cells. Cryopreserved DMCs were used for flow cytometric measurements, while isolated decidual &#x3b3;&#x3b4;T cells were co-cultured with choriocarcinoma cell lines or soluble HLA proteins.</p>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>Isolation of peripheral blood mononuclear cells</title>
<p>Heparinized peripheral blood was diluted with phosphate-buffered saline (PBS), and peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Paque&#x2122; (GE Healthcare) gradient centrifugation. Hereafter, the collected cells were washed and resuspended in RPMI1640 medium (Lonza) containing 20% fetal calf serum (Gibco<sup>&#xae;</sup>) supplemented with penicillin (1 x 10<sup>5</sup> U/L) (Lonza) and streptomycin (0.05 g/L) (Lonza), then incubated overnight at 37&#xb0;C and 5% CO<sub>2</sub>. The next morning cells were controlled for viability and split cryopreservation and isolation of &#x3b3;&#x3b4;T cells. Cryopreserved PBMCs were used for flow cytometric measurements, while isolated peripheral &#x3b3;&#x3b4;T cells were co-cultured with choriocarcinoma cell lines or soluble HLA proteins.</p>
</sec>
<sec id="s4_4">
<label>4.4</label>
<title>Cryopreservation</title>
<p>The washed cells were resuspended in heat-inactivated human serum containing 10% dimethyl sulfoxide and frozen at -80&#xb0;C utilizing MrFrosty&#x2122; Freezing Container (Thermo Scientific&#x2122;) for later analysis.</p>
</sec>
<sec id="s4_5">
<label>4.5</label>
<title>Isolation of &#x3b3;&#x3b4;T cells</title>
<p>Decidual and peripheral blood &#x3b3;&#x3b4;T cells were isolated using the &#x2018;TCR&#x3b3;/&#x3b4;<sup>+</sup> T cell Isolation Kit&#x2019; (Miltenyi Biotech) according to the manufacturer&#x2019;s instructions. The purity of the yielded &#x3b3;&#x3b4;T cells was determined by flow cytometry, and samples showing more than 90% &#x3b3;&#x3b4;T cells (&#x3b3;&#x3b4;TCR<sup>+</sup>/all living cells) were used for cell co-culture experiments (n=8). Although the precise composition of the antibody cocktail used in this kit is not publicly available, in-house testing confirmed the efficient elimination of CD56<sup>+</sup> cells.</p>
</sec>
<sec id="s4_6">
<label>4.6</label>
<title>Flow cytometry</title>    <p>Matched decidual and peripheral blood cryopreserved cells of 27 participants were thawed and transferred into prewarmed (37&#xb0;C) RPMI1640 medium (Lonza) supplemented with 10% fetal calf serum (Gibco<sup>&#xae;</sup>), penicillin (1 x 10<sup>5</sup> U/L) (Lonza) streptomycin (0.05 g/L) (Lonza), and DNase (20&#xb5;g/mL) (Sigma). Then, the cells were washed at 400x<italic>g</italic> for 7&#xa0;min, resuspended in protein-free PBS, distributed into round-bottom polystyrene tubes (2 x 10<sup>6</sup>/tube), and washed at 400x<italic>g</italic> for 7&#xa0;min in protein-free PBS. Consecutively, the cells were stained for viability (according to the manufacturer&#x2019;s instructions) and surface antigens (30&#xa0;min at RT in the dark). Then, the cells were fixed and permeabilized for intracellular target (Perforin, KIR2DL4) staining utilizing the InsideStain Kit (according to the manufacturer&#x2019;s instructions) (Miltenyi Biotec). The fluorochrome-conjugated antibodies used in each panel are summarized in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>. Finally, the cells were resuspended in PBS with 1% paraformaldehyde and stored in the dark at 4&#xb0;C until measurement on a Navios&#x2122; flow cytometer (Beckman Coulter). Due to low live cell count or poor sample quality, five decidual and four peripheral blood samples were excluded during preanalytical quality control in FlowJo&#x2122;. Compensation matrices were calculated by FlowJo&#x2122; using CompBeads (BD&#x2122;) and MACS<sup>&#xae;</sup> Comp Bead Kit, anti-REA (Miltenyi Biotec) for fluorochrome-labeled antibodies, and PBMCs for the viability dye. Gamma/delta T cells were defined as lymphocytes &#x2192; single cells &#x2192; ZombieNIR<sup>&#x2013;</sup>CD45<sup>+</sup>TCR&#x3b3;&#x3b4;<sup>+</sup> events. Decidual cells were further defined as residency marker (CD69) positive to exclude peripheral blood-derived cells in the decidual sample (<xref ref-type="bibr" rid="B68">68</xref>). All gates are based on fluorescence-minus-one controls (FMO; also see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information&#xa0;5</bold>
</xref>). Due to day-to-day variability and the different fluorophores, we standardized fluorescence intensity data to the individual FMO:</p>
<disp-formula>
<mml:math display="block" id="M1">
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>z</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>d</mml:mi>
<mml:mtext>&#x2004;</mml:mtext>
<mml:mi>F</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>e</mml:mi>
<mml:mtext>&#x2004;</mml:mtext>
<mml:mi>I</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>M</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>a</mml:mi>
<mml:msub>
<mml:mi>n</mml:mi>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>M</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>a</mml:mi>
<mml:msub>
<mml:mi>n</mml:mi>
<mml:mrow>
<mml:mi>F</mml:mi>
<mml:mi>M</mml:mi>
<mml:mi>O</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>b</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>t</mml:mi>
<mml:mtext>&#x2004;</mml:mtext>
<mml:mi>s</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>d</mml:mi>
<mml:mtext>&#x2004;</mml:mtext>
<mml:mi>d</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>v</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:msub>
<mml:mi>n</mml:mi>
<mml:mrow>
<mml:mi>F</mml:mi>
<mml:mi>M</mml:mi>
<mml:mi>O</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
</sec>
<sec id="s4_7">
<label>4.7</label>
<title>Cell (co-)culture</title>
<p>Three human choriocarcinoma cell lines (JAr) were used as model tissues: A standard JAr cell line (HLA class I<sup>&#x2013;</sup>) and the two JAr lines transfected with either HLA-E or HLA-G<sub>1m</sub> (JArE and JArG<sub>1m</sub>, respectively).</p>
<p>The cell lines were donated by P. Le Bouteiller (INSERM UMR 1043, Toulouse, France). JArG<sub>1m</sub> was produced by transfection of the pCDNA3/<italic>HLA-G1m</italic> plasmid, a gift of Dr. M. Lopez-Botet (Department of Immunology, University Hospital la Princesa, Madrid, Spain), in which the HLA-G leader sequence was modified as follows: the methionyl residue at position 2 was mutated to threonine; therefore, it could not provide a functional signal peptide for the expression of HLA-E ensuring the exclusive expression of HLA-G (<xref ref-type="bibr" rid="B69">69</xref>). JAR-E was transfected with a cd3.14 cosmid encoding HLA-E, a gift of M. Ulbrecht (Institute of Anthropology and Human Genetics, Munich, Germany) (<xref ref-type="bibr" rid="B70">70</xref>), in which the HLA-E leader sequence was replaced by that of HLA-A2, providing stable peptides for the expression of HLA-E, as described by Lee et&#xa0;al. (<xref ref-type="bibr" rid="B71">71</xref>). Upon arrival, aliquots of all cell lines were stored in our liquid nitrogen biobank. Low passage-count aliquots were thawed for our experiments. The cell lines were cultured in RPMI1640 medium (Lonza) supplemented with penicillin (1 x 10<sup>5</sup> U/L) (Lonza) and streptomycin (0.05 g/L) (Lonza), pyruvate (100mM) (Gibco<sup>&#xae;</sup>), geneticin (300 mg/mL) (Gibco<sup>&#xae;</sup>) for all transfectants and 10% fetal calf serum (Gibco<sup>&#xae;</sup>) at 37&#xb0;C and 5% CO<sub>2</sub>. The expression of HLA-E or HLA-G was regularly confirmed via flow cytometry (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>).</p>
<p>On the day of sample acquisition, cells of all three cell lines were seeded onto 96-well plates (30,000 cells/well). After that, cells were incubated at 37&#xb0;C and 5% CO<sub>2</sub> overnight for confluent growth.</p>
<p>On the next day, the old culture medium was carefully aspirated. Then, 100 &#xb5;L of freshly isolated, matched decidual and peripheral blood &#x3b3;&#x3b4;T cells (10<sup>6</sup> &#x3b3;&#x3b4;T cells/mL), resuspended in cell line culture medium, were pipetted into the wells. In addition to membrane-bound HLA-E and G<sub>1m</sub>, decidual and peripheral blood &#x3b3;&#x3b4;T cells were incubated with soluble HLA-E (0.5 &#xb5;g/mL) or HLA-G (0.5 &#xb5;g/mL) (both from OriGene Technologies) in independent wells. All tests were performed as biological duplicates. All wells were activated using ionomycin (1 &#xb5;g/mL) (Sigma-Aldrich) and phorbol myristate acetate (25 ng/mL) (Sigma-Aldrich) for 18h. Hereafter, the 96-well plates were centrifuged, and aliquots of the supernatants were cryopreserved at -80&#xb0;C for batched analysis.</p>
</sec>
<sec id="s4_8">
<label>4.8</label>
<title>Measurement of cell-(co-)culture supernatants</title>
<p>Diluted (1:10) cell culture supernatants were analyzed for IL-2 (6.5 &#x2013; 20,000), IL-4 (9.04 &#x2013; 14,000), IL-10 (5.06 &#x2013; 14,000), IL-6 (11.58 &#x2013; 15,000), IL-17A (8.51 &#x2013; 18,000), TNF-&#x3b1; (12.68 &#x2013; 12,000), sFas (4.53 &#x2013; 81,000), sFasL (7.37 &#x2013; 11,000), IFN-&#x3b3; (57.13 &#x2013; 20,000), granzyme A (62.96 &#x2013; 15,000), granzyme B (24.99 &#x2013; 52,000), perforin (60.18 &#x2013; 12,000) and granulysin (175.95 &#x2013; 57,000) utilizing the Human LegendPlex&#x2122; CD8/NK Panel (BioLegend) on a Canto 2 flow cytometer (BD Bioscience) according to the manufacturer&#x2019;s instructions.</p>
<p>Undiluted cell culture supernatants were analyzed for Angiopoietin-2 (13.7 &#x2013; 10,000), BMP-9 (2.7 &#x2013; 2,000), EGF (2.7 &#x2013; 2,000), Endoglin (13.7 &#x2013; 20,000), Endothelin-1 (2.7 &#x2013; 2,000), FGF-1 (13.7 &#x2013; 10,000), FGF-2 (13.7 &#x2013; 10,000), Follistatin (27.4 &#x2013; 10,000), G-CSF (13.7 &#x2013; 10,000), HB-EGF (1.4 &#x2013; 1,000), HGF (27.4 &#x2013; 20,000), IL-8 (1.4 &#x2013; 1,000), Leptin (137.2 &#x2013; 100,000), PLGF (6.9 &#x2013; 1,000), VEGF-A (13.7 &#x2013; 10,000), VEGF-C (6.9 &#x2013; 5,000) and VEGF-D (6.9 &#x2013; 5,000) utilizing the MILLIPLEX<sup>&#xae;</sup> Human Angiogenesis/Growth Factor Magnetic Bead Panel - Cancer Multiplex Assay Enzyme-linked Immunosorbent Assay (Millipore) according to the manufacturer&#x2019;s instructions. The parentheses&#x2019; numbers indicate each cytokine&#x2019;s detection range (pg/mL).</p>
</sec>
<sec id="s4_9">
<label>4.9</label>
<title>Statistics and data presentation</title>
<p>All statistical tests were performed in GraphPad Prism 9. Datasets were checked for Gaussian distribution by the D&#x2019;Agostino-Pearson omnibus normality test. The test used in each comparison is indicated in the respective figure legend. Generally, p-values &#x2264; 0.05 were considered significant. Illustrations were produced using BioRender and Adobe Illustrator 23.0.4. Plots of flow cytometric data were exported from FlowJo&#x2122;. Diagrams and Heatmaps were created using GraphPad Prism 9.</p>
</sec>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="s11">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by University of Pecs - Medical School, Ethics Committee (5643-PTE 2019, 5643-PTE 2023). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>JN: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Software, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. PV: Data curation, Investigation, Project administration, Writing &#x2013; review &amp; editing. IB: Data curation, Investigation, Methodology, Writing &#x2013; review &amp; editing. BF: Data curation, Formal analysis, Methodology, Validation, Writing &#x2013; review &amp; editing. AN: Conceptualization, Data curation, Methodology, Validation, Writing &#x2013; review &amp; editing. &#xc1;B: Data curation, Investigation, Validation, Writing &#x2013; review &amp; editing. DS: Data curation, Formal analysis, Investigation, Methodology, Writing &#x2013; review &amp; editing. SE-B: Data curation, Investigation, Methodology, Writing &#x2013; review &amp; editing. PJ: Data curation, Methodology, Resources, Supervision, Validation, Writing &#x2013; review &amp; editing. KK: Investigation, Resources, Supervision, Writing &#x2013; review &amp; editing. &#xc9;M: Writing &#x2013; review &amp; editing. TB: Funding acquisition, Resources, Supervision, Validation, Writing &#x2013; review &amp; editing. EM: Validation, Writing &#x2013; review &amp; editing, Funding acquisition, Project administration, Resources, Supervision. AB: Conceptualization, Data curation, Funding acquisition, Investigation, Project administration, Resources, Supervision, Validation, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. PTE &#xc1;OK-KA grants funded this research (No: KA-2019-28, KA-2019-37), the Thematic Excellence Program 2020 - Institutional Excellence Sub-program of the Ministry for Innovation and Technology in Hungary, within the framework of the second thematic program of the University of P&#xe9;cs and the European Union and co-financed by the European Social Fund: Comprehensive Development for Implementing Smart Specialization Strategies at the University of P&#xe9;cs (EFOP-3.6.1.-16-2016-00004). This work was supported by the National Research, Development and Innovation Fund of Hungary, financed under the TKP-2021-EGA-10 funding scheme. Further support was granted by the &#x201c;National Laboratory on Human Reproduction&#x201d;, project no. RRF-2.3.1-21-2022-00012, titled National Laboratory on Human Reproduction has been implemented with the support provided by the Recovery and Resilience Facility of the European Union within the framework of Programme Sz&#xe9;chenyi Plan Plus.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We are grateful to our participants for their sample donations. Furthermore, we thank Philippe Le Bouteiller for providing the JAr cell line and transfectants. The research was performed in collaboration with the Flow Cytometry Core Facility at the Szent&#xe1;gothai Research Centre of the University of P&#xe9;cs.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2024.1382424/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2024.1382424/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chavan</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Griffith</surname> <given-names>OW</given-names>
</name>
<name>
<surname>Wagner</surname> <given-names>GP</given-names>
</name>
</person-group>. <article-title>The inflammation paradox in the evolution of mammalian pregnancy: turning a foe into a friend</article-title>. <source>Curr Opin Genet Dev</source>. (<year>2017</year>) <volume>47</volume>:<fpage>24</fpage>&#x2013;<lpage>32</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.GDE.2017.08.004</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kieckbusch</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gaynor</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Moffett</surname> <given-names>A</given-names>
</name>
<name>
<surname>Colucci</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>MHC-dependent inhibition of uterine NK cells impedes fetal growth and decidual vascular remodelling</article-title>. <source>Nat Commun</source>. (<year>2014</year>) <volume>5</volume>:<fpage>3359</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms4359</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sharkey</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Kennedy</surname> <given-names>PR</given-names>
</name>
<name>
<surname>Gardner</surname> <given-names>L</given-names>
</name>
<name>
<surname>Farrell</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Chazara</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal uterine NK cell&#x2013;activating receptor KIR2DS1 enhances placentation</article-title>. <source>J Clin Invest</source>. (<year>2013</year>) <volume>123</volume>:<page-range>4264&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI68991</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Redman</surname> <given-names>CWG</given-names>
</name>
<name>
<surname>Sargent</surname> <given-names>IL</given-names>
</name>
</person-group>. <article-title>The pathogenesis of pre-eclampsia</article-title>. <source>Gynecol Obstet Fertil</source>. (<year>2001</year>) <volume>29</volume>:<page-range>518&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1297-9589(01)00180-1</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Redman</surname> <given-names>CWG</given-names>
</name>
<name>
<surname>Sargent</surname> <given-names>IL</given-names>
</name>
</person-group>. <article-title>Immunology of pre-eclampsia</article-title>. <source>Am J Reprod Immunol</source>. (<year>2010</year>) <volume>63</volume>:<page-range>534&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-0897.2010.00831.x</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sargent</surname> <given-names>IL</given-names>
</name>
<name>
<surname>Borzychowski</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Redman</surname> <given-names>CWG</given-names>
</name>
</person-group>. <article-title>Immunoregulation in normal pregnancy and pre-eclampsia: An overview</article-title>. <source>Reprod BioMed Online</source>. (<year>2006</year>) <volume>13</volume>:<page-range>680&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1472-6483(10)60659-1</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>FR</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>CQ</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Li</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Du</surname> <given-names>MR</given-names>
</name>
</person-group>. <article-title>Galectin-9 Promotes Human Trophoblast Cell Invasion through Matrix Metalloproteinase-2 and p38 Signaling Pathway</article-title>. <source>Reprod Dev Med</source>. (<year>2018</year>) <volume>2</volume>:<fpage>1</fpage>&#x2013;<lpage>17</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/2096-2924.232880/ASSET/6405C685-D230-4C38-BC38-43DBAE94C30F/ASSETS/GRAPHIC/2096-2924-02-01-101-F005.PNG</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinketova</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mourdjeva</surname> <given-names>M</given-names>
</name>
<name>
<surname>Oreshkova</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Human decidual stromal cells as a component of the implantation niche and a modulator of maternal immunity</article-title>. <source>J Pregnancy</source>. (<year>2016</year>) <volume>2016</volume>:<fpage>1</fpage>&#x2013;<lpage>17</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2016/8689436</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannon</surname> <given-names>T</given-names>
</name>
<name>
<surname>Innes</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Lash</surname> <given-names>GE</given-names>
</name>
<name>
<surname>Bulmer</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Robson</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>Effects of local decidua on trophoblast invasion and spiral artery remodeling in focal placenta creta &#x2013; An immunohistochemical study</article-title>. <source>Placenta</source>. (<year>2012</year>) <volume>33</volume>:<fpage>998</fpage>&#x2013;<lpage>1004</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.PLACENTA.2012.09.004</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hecht</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Karumanchi</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Shainker</surname> <given-names>SA</given-names>
</name>
</person-group>. <article-title>Immune cell infiltrate at the utero-placental interface is altered in placenta accreta spectrum disorders</article-title>. <source>Arch Gynecol Obstet</source>. (<year>2020</year>) <volume>301</volume>:<fpage>499</fpage>&#x2013;<lpage>507</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00404-020-05453-1</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Chollet</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Goodwin</surname> <given-names>TM</given-names>
</name>
</person-group>. <article-title>Clinical risk factors for placenta previa&#x2013;placenta accreta</article-title>. <source>Am J Obstet Gynecol</source>. (<year>1997</year>) <volume>177</volume>:<page-range>210&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0002-9378(97)70463-0</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferry</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Starkey</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Sargent</surname> <given-names>IL</given-names>
</name>
<name>
<surname>Watt</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Jackson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Redman</surname> <given-names>CW</given-names>
</name>
</person-group>. <article-title>Cell populations in the human early pregnancy decidua: natural killer activity and response to interleukin-2 of CD56-positive large granular lymphocytes</article-title>. <source>Immunology</source>. (<year>1990</year>) <volume>70</volume>:<page-range>446&#x2013;52</page-range>.</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crespo</surname> <given-names>&#xc2;C</given-names>
</name>
<name>
<surname>Strominger</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Tilburgs</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2016</year>) <volume>113</volume>:<page-range>15072&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1617927114</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colucci</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>The role of KIR and HLA interactions in pregnancy complications</article-title>. <source>Immunogenetics</source>. (<year>2017</year>) <volume>69</volume>:<page-range>557&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00251-017-1003-9</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flores</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Marcos</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Paladino</surname> <given-names>N</given-names>
</name>
<name>
<surname>Arruvito</surname> <given-names>L</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>F</given-names>
</name>
<name>
<surname>Middleton</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>KIR receptors and HLA-C in the maintenance of pregnancy</article-title>. <source>Tissue Antigens</source>. (<year>2007</year>) <volume>69</volume>:<page-range>112&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1399-0039.2006.762_8.x</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ponte</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cantoni</surname> <given-names>C</given-names>
</name>
<name>
<surname>Biassoni</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tradori-Cappai</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bentivoglio</surname> <given-names>G</given-names>
</name>
<name>
<surname>Vitale</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>1999</year>) <volume>96</volume>:<page-range>5674&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.96.10.5674</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marlin</surname> <given-names>R</given-names>
</name>
<name>
<surname>Duriez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Berkane</surname> <given-names>N</given-names>
</name>
<name>
<surname>de Truchis</surname> <given-names>C</given-names>
</name>
<name>
<surname>Madec</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Rey-Cuille</surname> <given-names>M-A</given-names>
</name>
<etal/>
</person-group>. <article-title>Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy</article-title>. <source>PloS One</source>. (<year>2012</year>) <volume>7</volume>:<elocation-id>e30017</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0030017</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMaster</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Librach</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>KH</given-names>
</name>
<name>
<surname>Janatpour</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>DeMars</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Human placental HLA-G expression is restricted to differentiated cytotrophoblasts</article-title>. <source>J Immunol</source>. (<year>1995</year>) <volume>154</volume>:<page-range>3771&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.154.8.3771</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hutter</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hammer</surname> <given-names>A</given-names>
</name>
<name>
<surname>Blaschitz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hartmann</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ebbesen</surname> <given-names>P</given-names>
</name>
<name>
<surname>Dohr</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Expression of HLA class I molecules in human first trimester and term placenta trophoblast</article-title>. <source>Cell Tissue Res</source>. (<year>1996</year>) <volume>286</volume>:<page-range>439&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s004410050713</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfeiffer</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Rebmann</surname> <given-names>V</given-names>
</name>
<name>
<surname>P&#xe4;ssler</surname> <given-names>M</given-names>
</name>
<name>
<surname>van der Ven</surname> <given-names>K</given-names>
</name>
<name>
<surname>van der Ven</surname> <given-names>H</given-names>
</name>
<name>
<surname>Krebs</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Soluble HLA levels in early pregnancy after in <italic>vitro</italic> fertilization</article-title>. <source>Hum Immunol</source>. (<year>2000</year>) <volume>61</volume>:<page-range>559&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0198-8859(00)00123-3</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunt</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Jadhav</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Geraghty</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Ober</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Soluble HLA-G circulates in maternal blood during pregnancy</article-title>. <source>Am J Obstet Gynecol</source>. (<year>2000</year>) <volume>183</volume>:<page-range>682&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1067/mob.2000.106762</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beneventi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Locatelli</surname> <given-names>E</given-names>
</name>
<name>
<surname>De Amici</surname> <given-names>M</given-names>
</name>
<name>
<surname>Martinetti</surname> <given-names>M</given-names>
</name>
<name>
<surname>Spinillo</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Soluble HLA-G concentrations in obese women during pregnancy and in cord blood</article-title>. <source>J Reprod Immunol</source>. (<year>2017</year>) <volume>119</volume>:<page-range>31&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jri.2016.11.005</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steinborn</surname> <given-names>A</given-names>
</name>
<name>
<surname>Varkonyi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Scharf</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bahlmann</surname> <given-names>F</given-names>
</name>
<name>
<surname>Klee</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sohn</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy</article-title>. <source>Am J Reprod Immunol</source>. (<year>2007</year>) <volume>57</volume>:<page-range>277&#x2013;86</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-0897.2007.00475.x</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunne</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Elliott</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hussey</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mahmud</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>J</given-names>
</name>
<name>
<surname>Doherty</surname> <given-names>DG</given-names>
</name>
<etal/>
</person-group>. <article-title>Persistent changes in circulating and intestinal &#x3b3;&#x3b4; T cell subsets, invariant natural killer T cells and mucosal-associated invariant T cells in children and adults with coeliac disease</article-title>. <source>PloS One</source>. (<year>2013</year>) <volume>8</volume>:<fpage>e76008</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0076008</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gully</surname> <given-names>BS</given-names>
</name>
<name>
<surname>Rossjohn</surname> <given-names>J</given-names>
</name>
<name>
<surname>Davey</surname> <given-names>MS</given-names>
</name>
</person-group>. <article-title>Our evolving understanding of the role of the &#x3b3;&#x3b4; T cell receptor in &#x3b3;&#x3b4; T cell mediated immunity</article-title>. <source>Biochem Soc Trans</source>. (<year>2021</year>) <volume>49</volume>:<page-range>1985&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BST20200890</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terzieva</surname> <given-names>A</given-names>
</name>
<name>
<surname>Dimitrova</surname> <given-names>V</given-names>
</name>
<name>
<surname>Djerov</surname> <given-names>L</given-names>
</name>
<name>
<surname>Dimitrova</surname> <given-names>P</given-names>
</name>
<name>
<surname>Zapryanova</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hristova</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Early pregnancy human decidua is enriched with activated, fully differentiated and pro-inflammatory gamma/delta T cells with diverse TCR repertoires</article-title>. <source>Int J Mol Sci</source>. (<year>2019</year>) <volume>20</volume>:<elocation-id>687</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms20030687</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilburgs</surname> <given-names>T</given-names>
</name>
<name>
<surname>van der Mast</surname> <given-names>BJ</given-names>
</name>
<name>
<surname>Nagtzaam</surname> <given-names>NMA</given-names>
</name>
<name>
<surname>Roelen</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Scherjon</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Claas</surname> <given-names>FHJ</given-names>
</name>
</person-group>. <article-title>Expression of NK cell receptors on decidual T cells in human pregnancy</article-title>. <source>J Reprod Immunol</source>. (<year>2009</year>) <volume>80</volume>:<fpage>22</fpage>&#x2013;<lpage>32</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.JRI.2009.02.004</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>DX</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>MQ</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Li</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>LP</given-names>
</name>
</person-group>. <article-title>The decidual gamma-delta T cells up-regulate the biological functions of trophoblasts <italic>via</italic> IL-10 secretion in early human pregnancy</article-title>. <source>Clin Immunol</source>. (<year>2011</year>) <volume>141</volume>:<page-range>284&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.clim.2011.07.008</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moser</surname> <given-names>G</given-names>
</name>
<name>
<surname>Weiss</surname> <given-names>G</given-names>
</name>
<name>
<surname>Gauster</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sundl</surname> <given-names>M</given-names>
</name>
<name>
<surname>Huppertz</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Evidence from the very beginning: endoglandular trophoblasts penetrate and replace uterine glands <italic>in situ</italic> and <italic>in vitro</italic>
</article-title>. <source>Hum Reprod</source>. (<year>2015</year>) <volume>30</volume>:<page-range>2747&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humrep/dev266</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carson</surname> <given-names>DD</given-names>
</name>
<name>
<surname>Bagchi</surname> <given-names>I</given-names>
</name>
<name>
<surname>Dey</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Enders</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Fazleabas</surname> <given-names>AT</given-names>
</name>
<name>
<surname>Lessey</surname> <given-names>BA</given-names>
</name>
<etal/>
</person-group>. <article-title>Embryo implantation</article-title>. <source>Dev Biol</source>. (<year>2000</year>) <volume>223</volume>:<page-range>217&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/DBIO.2000.9767</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hempstock</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cindrova-Davies</surname> <given-names>T</given-names>
</name>
<name>
<surname>Jauniaux</surname> <given-names>E</given-names>
</name>
<name>
<surname>Burton</surname> <given-names>GJ</given-names>
</name>
</person-group>. <article-title>Endometrial glands as a source of nutrients, growth factors and cytokines during the first trimester of human pregnancy: A morphological and immunohistochemical study</article-title>. <source>Reprod Biol Endocrinol</source>. (<year>2004</year>) <volume>2</volume>:<elocation-id>58</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1477-7827-2-58</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaiser</surname> <given-names>BK</given-names>
</name>
<name>
<surname>Barahmand-pour</surname> <given-names>F</given-names>
</name>
<name>
<surname>Paulsene</surname> <given-names>W</given-names>
</name>
<name>
<surname>Medley</surname> <given-names>S</given-names>
</name>
<name>
<surname>Geraghty</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Strong</surname> <given-names>RK</given-names>
</name>
</person-group>. <article-title>Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics</article-title>. <source>J Immunol</source>. (<year>2005</year>) <volume>174</volume>:<page-range>2878&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/JIMMUNOL.174.5.2878</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Navarro</surname> <given-names>F</given-names>
</name>
<name>
<surname>Llano</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bell&#xf3;n</surname> <given-names>T</given-names>
</name>
<name>
<surname>Colonna</surname> <given-names>M</given-names>
</name>
<name>
<surname>Geraghty</surname> <given-names>DE</given-names>
</name>
<name>
<surname>L&#xf3;pez-Botet</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells</article-title>. <source>Eur J Immunol</source>. (<year>1999</year>) <volume>29</volume>:<page-range>277&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(199901)29:01&lt;277::AID-IMMU277&gt;3.0.CO;2-4</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>LA</given-names>
</name>
</person-group>. <article-title>Residues Met76 and Gln79 in HLA-G &#x3b1;1 domain involved in KIR2DL4 recognition</article-title>. <source>Cell Res</source>. (<year>2005</year>) <volume>15</volume>:<page-range>176&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.cr.7290283</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajagopalan</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Endosomal signaling and a novel pathway defined by the natural killer receptor KIR2DL4 (CD158d)</article-title>. <source>Traffic</source>. (<year>2010</year>) <volume>11</volume>:<page-range>1381&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-0854.2010.01112.x</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajagopalan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Long</surname> <given-names>EO</given-names>
</name>
</person-group>. <article-title>Cutting edge: induction of IFN-&#x3b3; Production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells</article-title>. <source>J Immunol</source>. (<year>2001</year>) <volume>167</volume>:<page-range>1877&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.167.4.1877</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyson</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Rybalov</surname> <given-names>B</given-names>
</name>
<name>
<surname>Koopman</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Exley</surname> <given-names>M</given-names>
</name>
<name>
<surname>Balk</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Racke</surname> <given-names>FK</given-names>
</name>
<etal/>
</person-group>. <article-title>CD1d and invariant NKT cells at the human maternal-fetal interface</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2002</year>) <volume>99</volume>:<page-range>13741&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.162491699</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsumoto</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kawana</surname> <given-names>K</given-names>
</name>
<name>
<surname>Nagamatsu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Schust</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Fujii</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Expression of surface CD1d in the extravillous trophoblast cells of early gestational placenta is downregulated in a manner dependent on trophoblast differentiation</article-title>. <source>Biochem Biophys Res Commun</source>. (<year>2008</year>) <volume>371</volume>:<page-range>236&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2008.04.051</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jenkinson</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Wainwright</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Simpson</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Perry</surname> <given-names>ACF</given-names>
</name>
<name>
<surname>Fotiadou</surname> <given-names>P</given-names>
</name>
<name>
<surname>Holmes</surname> <given-names>CH</given-names>
</name>
</person-group>. <article-title>Expression of CD1D mRNA transcripts in human choriocarcinoma cell lines and placentally derived trophoblast cells</article-title>. <source>Immunology</source>. (<year>1999</year>) <volume>96</volume>:<page-range>649&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2567.1999.00726.x</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lesport</surname> <given-names>E</given-names>
</name>
<name>
<surname>Baudhuin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sousa</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lemaoult</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zamborlini</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rouas-Freiss</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibition of human V&#x3b3;9V&#x3b4;2 T-cell antitumoral activity through HLA-G: Implications for immunotherapy of cancer</article-title>. <source>Cell Mol Life Sci</source>. (<year>2011</year>) <volume>68</volume>:<page-range>3385&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018-011-0632-7</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Zwan</surname> <given-names>A</given-names>
</name>
<name>
<surname>van Unen</surname> <given-names>V</given-names>
</name>
<name>
<surname>Beyrend</surname> <given-names>G</given-names>
</name>
<name>
<surname>Laban</surname> <given-names>S</given-names>
</name>
<name>
<surname>van der Keur</surname> <given-names>C</given-names>
</name>
<name>
<surname>Kapsenberg</surname> <given-names>HJM</given-names>
</name>
<etal/>
</person-group>. <article-title>Visualizing dynamic changes at the maternal-fetal interface throughout human pregnancy by mass cytometry</article-title>. <source>Front Immunol</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>571300</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.571300</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandstrom</surname> <given-names>A</given-names>
</name>
<name>
<surname>Peign&#xe9;</surname> <given-names>C-M</given-names>
</name>
<name>
<surname>L&#xe9;ger</surname> <given-names>A</given-names>
</name>
<name>
<surname>Crooks</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Konczak</surname> <given-names>F</given-names>
</name>
<name>
<surname>Gesnel</surname> <given-names>M-C</given-names>
</name>
<etal/>
</person-group>. <article-title>The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human V&#x3b3;9V&#x3b4;2 T cells</article-title>. <source>Immunity</source>. (<year>2014</year>) <volume>40</volume>:<fpage>490</fpage>&#x2013;<lpage>500</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2014.03.003</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhodes</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H-C</given-names>
</name>
<name>
<surname>Price</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Keeble</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Davey</surname> <given-names>MS</given-names>
</name>
<name>
<surname>James</surname> <given-names>LC</given-names>
</name>
<etal/>
</person-group>. <article-title>Activation of human &#x3b3;&#x3b4; T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin</article-title>. <source>J Immunol</source>. (<year>2015</year>) <volume>194</volume>:<page-range>2390&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1401064</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harly</surname> <given-names>C</given-names>
</name>
<name>
<surname>Guillaume</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Nedellec</surname> <given-names>S</given-names>
</name>
<name>
<surname>Peign&#xe9;</surname> <given-names>C-M</given-names>
</name>
<name>
<surname>M&#xf6;nkk&#xf6;nen</surname> <given-names>H</given-names>
</name>
<name>
<surname>M&#xf6;nkk&#xf6;nen</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human &#x3b3;&#x3b4; T-cell subset</article-title>. <source>Blood</source>. (<year>2012</year>) <volume>120</volume>:<page-range>2269&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2012-05-430470</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rigau</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ostrouska</surname> <given-names>S</given-names>
</name>
<name>
<surname>Fulford</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>DN</given-names>
</name>
<name>
<surname>Woods</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ruan</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Butyrophilin 2A1 is essential for phosphoantigen reactivity by &#x3b3;&#x3b4; T cells</article-title>. <source>Sci (1979)</source>. (<year>2020</year>) <volume>367</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.aay5516</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uldrich</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Le Nours</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pellicci</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Gherardin</surname> <given-names>NA</given-names>
</name>
<name>
<surname>Mcpherson</surname> <given-names>KG</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>RT</given-names>
</name>
<etal/>
</person-group>. <article-title>CD1d-lipid antigen recognition by the &#x3b3;&#x3b4; TCR</article-title>. <source>Nat Immunol</source>. (<year>2013</year>) <volume>14</volume>:<page-range>1137&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.2713</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Nours</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gherardin</surname> <given-names>NA</given-names>
</name>
<name>
<surname>Ramarathinam</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Awad</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wiede</surname> <given-names>F</given-names>
</name>
<name>
<surname>Gully</surname> <given-names>BS</given-names>
</name>
<etal/>
</person-group>. <article-title>A class of gd T cell receptors recognize the underside of the antigen-presenting molecule MR1</article-title>. <source>Sci (1979)</source>. (<year>2019</year>) <volume>366</volume>:<page-range>1522&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.aav3900</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ly</surname> <given-names>D</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Li</surname> <given-names>N-S</given-names>
</name>
<name>
<surname>Hawk</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Altman</surname> <given-names>JD</given-names>
</name>
<etal/>
</person-group>. <article-title>Molecular analysis of lipid-reactive V&#x3b4;1 &#x3b3;&#x3b4; T cells identified by CD1c tetramers</article-title>. <source>J Immunol</source>. (<year>2016</year>) <volume>196</volume>:<page-range>1933&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1502202</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reijneveld</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Ocampo</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Shahine</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gully</surname> <given-names>BS</given-names>
</name>
<name>
<surname>Vantourout</surname> <given-names>P</given-names>
</name>
<name>
<surname>Hayday</surname> <given-names>AC</given-names>
</name>
<etal/>
</person-group>. <article-title>Human &#x3b3;&#x3b4; T cells recognize CD1b by two distinct mechanisms</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2020</year>) <volume>117</volume>:<page-range>22944&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.2010545117</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groh</surname> <given-names>V</given-names>
</name>
<name>
<surname>Steinle</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bauer</surname> <given-names>S</given-names>
</name>
<name>
<surname>Spies</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Recognition of stress-induced MHC molecules by intestinal epithelial &#x3b3;&#x3b4; T cells</article-title>. <source>Sci (1979)</source>. (<year>1998</year>) <volume>279</volume>:<page-range>1737&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.279.5357.1737</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname> <given-names>D</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Changes of &#x3b3;&#x3b4;T cell subtypes during pregnancy and their influences in spontaneous abortion</article-title>. <source>J Reprod Immunol</source>. (<year>2019</year>) <volume>131</volume>:<fpage>57</fpage>&#x2013;<lpage>62</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jri.2019.01.003</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manchorova</surname> <given-names>D</given-names>
</name>
<name>
<surname>Papadopoulou</surname> <given-names>M</given-names>
</name>
<name>
<surname>Alexandrova</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dimitrova</surname> <given-names>V</given-names>
</name>
<name>
<surname>Djerov</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zapryanova</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Human decidual gamma/delta T cells possess unique effector and TCR repertoire profiles during pregnancy</article-title>. <source>Cell Immunol</source>. (<year>2022</year>) <volume>382</volume>:<elocation-id>104634</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.CELLIMM.2022.104634</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mangan</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Dunne</surname> <given-names>MR</given-names>
</name>
<name>
<surname>O&#x2019;Reilly</surname> <given-names>VP</given-names>
</name>
<name>
<surname>Dunne</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Exley</surname> <given-names>MA</given-names>
</name>
<name>
<surname>O&#x2019;Shea</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human V&#x3b4;3 T cells</article-title>. <source>J Immunol</source>. (<year>2013</year>) <volume>191</volume>:<page-range>30&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/JIMMUNOL.1300121</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braud</surname> <given-names>VM</given-names>
</name>
<name>
<surname>Allan</surname> <given-names>DSJ</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>D</given-names>
</name>
<name>
<surname>McMichael</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide</article-title>. <source>Curr Biol</source>. (<year>1998</year>) <volume>8</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0960-9822(98)70014-4</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braud</surname> <given-names>V</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>EY</given-names>
</name>
<name>
<surname>McMichael</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9</article-title>. <source>Eur J Immunol</source>. (<year>1997</year>) <volume>27</volume>:<page-range>1164&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/EJI.1830270517</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>C</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment</article-title>. <source>Mol Cancer</source>. (<year>2023</year>) <volume>22</volume>:<fpage>1</fpage>&#x2013;<lpage>23</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/S12943-023-01722-0</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>A</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>WH</given-names>
</name>
</person-group>. <article-title>Intercellular transfer of HLA-G: its potential in cancer immunology</article-title>. <source>Clin Transl Immunol</source>. (<year>2019</year>) <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/CTI2.1077</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajagopalan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Long</surname> <given-names>EO</given-names>
</name>
</person-group>. <article-title>Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2012</year>) <volume>109</volume>:<page-range>20596&#x2013;601</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1208248109</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>P</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ning</surname> <given-names>F</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Vitamin D promotes trophoblast cell induced separation of vascular smooth muscle cells in vascular remodeling <italic>via</italic> induction of G-CSF</article-title>. <source>Front Cell Dev Biol</source>. (<year>2020</year>) <volume>8</volume>:<elocation-id>601043/BIBTEX</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2020.601043</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>M2 macrophage-derived G-CSF promotes trophoblasts EMT, invasion and migration <italic>via</italic> activating PI3K/Akt/Erk1/2 pathway to mediate normal pregnancy</article-title>. <source>J Cell Mol Med</source>. (<year>2021</year>) <volume>25</volume>:<page-range>2136&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/JCMM.16191</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paiva</surname> <given-names>P</given-names>
</name>
<name>
<surname>Hannan</surname> <given-names>NJ</given-names>
</name>
<name>
<surname>Hincks</surname> <given-names>C</given-names>
</name>
<name>
<surname>Meehan</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Pruysers</surname> <given-names>E</given-names>
</name>
<name>
<surname>Dimitriadis</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Human chorionic gonadotrophin regulates FGF2 and other cytokines produced by human endometrial epithelial cells, providing a mechanism for enhancing endometrial receptivity</article-title>. <source>Hum Reprod</source>. (<year>2011</year>) <volume>26</volume>:<page-range>1153&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/HUMREP/DER027</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheridan</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Fernando</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Gardner</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hollinshead</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Burton</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Moffett</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Establishment and differentiation of long-term trophoblast organoid cultures from the human placenta</article-title>. <source>Nat Protoc</source> (<year>2020</year>), <page-range>3441&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41596-020-0381-x</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Islami</surname> <given-names>D</given-names>
</name>
<name>
<surname>Bischof</surname> <given-names>P</given-names>
</name>
<name>
<surname>Chardonnens</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Modulation of placental vascular endothelial growth factor by leptin and hCG</article-title>. <source>Mol Hum Reprod</source>. (<year>2003</year>) <volume>9</volume>:<page-range>395&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/MOLEHR/GAG053</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrientos</surname> <given-names>G</given-names>
</name>
<name>
<surname>Toro</surname> <given-names>A</given-names>
</name>
<name>
<surname>Moschansky</surname> <given-names>P</given-names>
</name>
<name>
<surname>Cohen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Garcia</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Rose</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Leptin promotes HLA-G expression on placental trophoblasts <italic>via</italic> the MEK/Erk and PI3K signaling pathways</article-title>. <source>Placenta</source>. (<year>2015</year>) <volume>36</volume>:<page-range>419&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.PLACENTA.2015.01.006</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chau</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hennessy</surname> <given-names>A</given-names>
</name>
<name>
<surname>Makris</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Placental growth factor and pre-eclampsia</article-title>. <source>J Hum Hypertension</source>. (<year>2017</year>) <volume>31</volume>:<page-range>782&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/jhh.2017.61</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colucci</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Uterine NK cells ace an &#x201c;A&#x201d; in education: NKG2A sets up crucial functions at the maternal&#x2013;fetal interface</article-title>. <source>J Immunol</source>. (<year>2022</year>) <volume>209</volume>:<page-range>1421&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/JIMMUNOL.2200384</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crespo</surname> <given-names>&#xc2;C</given-names>
</name>
<name>
<surname>Mulik</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dotiwala</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ansara</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Sen Santara</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ingersoll</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Decidual NK cells transfer granulysin to selectively kill bacteria in trophoblasts</article-title>. <source>Cell</source>. (<year>2020</year>) <volume>182</volume>:<fpage>1125</fpage>&#x2013;<lpage>1139.e18</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.CELL.2020.07.019</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bj&#xf6;rkstr&#xf6;m</surname> <given-names>NK</given-names>
</name>
<name>
<surname>Ljunggren</surname> <given-names>HG</given-names>
</name>
<name>
<surname>Micha&#xeb;lsson</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Emerging insights into natural killer cells in human peripheral tissues</article-title>. <source>Nat Rev Immunol</source>. (<year>2016</year>) <volume>16</volume>:<page-range>310&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri.2016.34</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llano</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>N</given-names>
</name>
<name>
<surname>Navarro</surname> <given-names>F</given-names>
</name>
<name>
<surname>Garc&#xed;a</surname> <given-names>P</given-names>
</name>
<name>
<surname>Albar</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Geraghty</surname> <given-names>DE</given-names>
</name>
<etal/>
</person-group>. <article-title>HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer</article-title>. <source>Eur J Immunol</source>. (<year>1998</year>) <volume>28</volume>:<page-range>2854&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(199809)28:09&lt;2854::AID-IMMU2854&gt;3.0.CO;2-W</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulbrecht</surname> <given-names>M</given-names>
</name>
<name>
<surname>Honka</surname> <given-names>T</given-names>
</name>
<name>
<surname>Person</surname> <given-names>S</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Weiss</surname> <given-names>EH</given-names>
</name>
</person-group>. <article-title>The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein</article-title>. <source>J Immunol</source>. (<year>1992</year>) <volume>149</volume>:<page-range>2945&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.149.9.2945</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>N</given-names>
</name>
<name>
<surname>Goodlett</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Ishitani</surname> <given-names>A</given-names>
</name>
<name>
<surname>Marquardt</surname> <given-names>H</given-names>
</name>
<name>
<surname>Geraghty</surname> <given-names>DE</given-names>
</name>
</person-group>. <article-title>HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences</article-title>. <source>J Immunol</source>. (<year>1998</year>) <volume>160</volume>:<fpage>160</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.160.10.4951</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>